HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Frank Corvino also recently made the following trade(s):
- On Tuesday, October 1st, Frank Corvino sold 1,247 shares of HealthEquity stock. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22.
HealthEquity Stock Performance
Shares of HQY stock opened at $98.82 on Friday. The company has a market cap of $8.63 billion, a P/E ratio of 82.35, a PEG ratio of 1.53 and a beta of 0.52. The firm has a fifty day moving average price of $83.15 and a 200 day moving average price of $80.43. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12 month low of $62.10 and a 12 month high of $99.57.
Hedge Funds Weigh In On HealthEquity
Several hedge funds have recently added to or reduced their stakes in HQY. International Assets Investment Management LLC purchased a new position in HealthEquity during the 2nd quarter worth approximately $35,000. Paladin Wealth LLC acquired a new position in shares of HealthEquity in the 3rd quarter valued at $39,000. GAMMA Investing LLC raised its position in HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after purchasing an additional 318 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in HealthEquity during the 2nd quarter worth $73,000. Finally, 1620 Investment Advisors Inc. purchased a new position in HealthEquity during the 3rd quarter worth $112,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on the stock. Barrington Research restated an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. JMP Securities reaffirmed a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Bank of America decreased their price objective on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, September 4th. Royal Bank of Canada restated an “outperform” rating and set a $92.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of $103.83.
Check Out Our Latest Report on HQY
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- What is a Bond Market Holiday? How to Invest and Trade
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- With Risk Tolerance, One Size Does Not Fit All
- MarketBeat Week in Review – 11/4 – 11/8
- What is an Earnings Surprise?
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.